Literature DB >> 25377088

Loss of mitochondrial exo/endonuclease EXOG affects mitochondrial respiration and induces ROS-mediated cardiomyocyte hypertrophy.

Wardit Tigchelaar1, Hongjuan Yu2, Anne Margreet de Jong1, Wiek H van Gilst1, Pim van der Harst1, B Daan Westenbrink1, Rudolf A de Boer1, Herman H W Silljé3.   

Abstract

Recently, a locus at the mitochondrial exo/endonuclease EXOG gene, which has been implicated in mitochondrial DNA repair, was associated with cardiac function. The function of EXOG in cardiomyocytes is still elusive. Here we investigated the role of EXOG in mitochondrial function and hypertrophy in cardiomyocytes. Depletion of EXOG in primary neonatal rat ventricular cardiomyocytes (NRVCs) induced a marked increase in cardiomyocyte hypertrophy. Depletion of EXOG, however, did not result in loss of mitochondrial DNA integrity. Although EXOG depletion did not induce fetal gene expression and common hypertrophy pathways were not activated, a clear increase in ribosomal S6 phosphorylation was observed, which readily explains increased protein synthesis. With the use of a Seahorse flux analyzer, it was shown that the mitochondrial oxidative consumption rate (OCR) was increased 2.4-fold in EXOG-depleted NRVCs. Moreover, ATP-linked OCR was 5.2-fold higher. This increase was not explained by mitochondrial biogenesis or alterations in mitochondrial membrane potential. Western blotting confirmed normal levels of the oxidative phosphorylation (OXPHOS) complexes. The increased OCR was accompanied by a 5.4-fold increase in mitochondrial ROS levels. These increased ROS levels could be normalized with specific mitochondrial ROS scavengers (MitoTEMPO, mnSOD). Remarkably, scavenging of excess ROS strongly attenuated the hypertrophic response. In conclusion, loss of EXOG affects normal mitochondrial function resulting in increased mitochondrial respiration, excess ROS production, and cardiomyocyte hypertrophy.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  ROS; cardiomyocytes; hypertrophy; mitochondria; mitochondrial respiration

Mesh:

Substances:

Year:  2014        PMID: 25377088     DOI: 10.1152/ajpcell.00227.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  A unique exonuclease ExoG cleaves between RNA and DNA in mitochondrial DNA replication.

Authors:  Chyuan-Chuan Wu; Jason L J Lin; Hsin-Fang Yang-Yen; Hanna S Yuan
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

2.  Age Related Bioenergetics Profiles in Isolated Rat Cardiomyocytes Using Extracellular Flux Analyses.

Authors:  Kennedy S Mdaki; Tricia D Larsen; Lucinda J Weaver; Michelle L Baack
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

3.  A domain in human EXOG converts apoptotic endonuclease to DNA-repair exonuclease.

Authors:  Michal R Szymanski; Wangsheng Yu; Aleksandra M Gmyrek; Mark A White; Ian J Molineux; J Ching Lee; Y Whitney Yin
Journal:  Nat Commun       Date:  2017-05-03       Impact factor: 14.919

Review 4.  Human mitochondrial nucleases.

Authors:  Francesco Bruni; Robert N Lightowlers; Zofia M Chrzanowska-Lightowlers
Journal:  FEBS J       Date:  2017-02-01       Impact factor: 5.542

5.  The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy.

Authors:  Lei Yang; Di Yu; Ran Mo; Jiru Zhang; Hu Hua; Liang Hu; Yu Feng; Song Wang; Wei-Yan Zhang; Ning Yin; Xu-Ming Mo
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

Review 6.  Oxidative Stress and Cardiac Remodeling: An Updated Edge.

Authors:  Abeer M Rababa'h; Ashley N Guillory; Rima Mustafa; Tamara Hijjawi
Journal:  Curr Cardiol Rev       Date:  2018-03-14

7.  Structural insights into DNA degradation by human mitochondrial nuclease MGME1.

Authors:  Chun Yang; Ruiqi Wu; Hehua Liu; Yiqing Chen; Yanqing Gao; Xi Chen; Yangyang Li; Jinbiao Ma; Jixi Li; Jianhua Gan
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.